Swiss patients with variegate porphyria have unique mutations

Swiss Medical Weekly

Volumn 136, Issue 31-32, 2006, Pages 515-519

  Schneider Yin, Xiaoye ^a   Minder, Elisabeth I ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Faecal porphyrin excretion; Genotype phenotype correlation; Mutation; Protoporphyrinogen oxidase; Variegate porphyria

Indexed keywords

PORPHYRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GENE INSERTION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; NEUROLOGIC DISEASE; PORPHYRIA VARIEGATA; SKIN DISEASE; SWITZERLAND;

EID: 33748774667     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Anderson K, Sassa S, Bishop D, Desnick R. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Basis of Inherited Disease, 8th edn. New York: McGraw-Hill, 2001;2991-3062.
2. Hift R, Davidson B, van der Hooft C, Meissner D, Meissner P. Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with detection of protoporphyrinogen oxidase mutations as a reference standard. Clin Chem 2004;50:915-23.
3. Hift RJ, Meissner PN. An analysis of 112 acute porphyric attacks in Cape Town, South Africa: Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity. Medicine (Baltimore) 2005;84:48-60.
4. Kirsch R, Meissner P, Hift R. Variegate porphyria. Sem Liver Dis 1998;18:33-41.
5. Nishimura K, Taketani S, Inokuchi H. Cloning of a human cDNA for protoporphyrinogen oxidase by complementation in vivo of a hemG mutant of Escherichia coli. J Biol Chem 1995;270:8076-80.
6. Taketani S, Inazawa J, Abe T, Furukawa T, Kohno H, Tokunaga R, et al. The human protoporphyrinogen oxidase gene (PPOX): organization and location to chromosome 1. Genomics 1995;29:698-703.
7. Whatley S, Puy H, Morgan R, Robreau A, Roberts A, Nordmann Y, et al. Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. Am J Hum Genet 1999;65:984-94.
8. Minder EI, Vuilleumier JP, Vonderschmitt DJ. Prototype application of a robot in the clinical laboratory enabling fully automated quantification of fecal porphyrins. Clin Chem 1992;38:516-21.
9. Poh-Fitzpatrick M. A plasma porphyrin fluorescence marker for variegate porphyria. Arch Dermatol 1980;116:543-7.
10. Minder EI. Coproporphyrin isomers in acute-intermittent porphyria. Scand J Clin Lab Invest 1993;53:87-90.
11. Frank J, Jugert FK, Merk HF, Kalka K, Goerz G, Anderson K, et al. A spectrum of novel mutations in the protoporphyrinogen oxidase gene in 13 families with variegate porphyria. J Invest Dermatol 2001;116:821-3.
12. Eales L, Day R, Blekkenhorst G. The clinical and biochemical features of variegate porphyria: an analysis of 300 cases studied at Groote Schuur Hospital, Cape Town. Int J Biochem 1980;12:837-53.
13. Warnich L, Kimberg M, Kotze MJ, Ohashi T, Taketani S, Louw BJ. Haplotype analysis excludes the functional protoporphyrinogen oxidase promoter polymorphism -1081G>A as a modifying factor in the clinical expression of variegate porphyria. Cell Mol Biol (Noisy-le-grand) 2002;48:57-60.